xamoterol has been researched along with carteolol in 2 studies
| Studies (xamoterol) | Trials (xamoterol) | Recent Studies (post-2010) (xamoterol) | Studies (carteolol) | Trials (carteolol) | Recent Studies (post-2010) (carteolol) |
|---|---|---|---|---|---|
| 269 | 80 | 17 | 355 | 93 | 40 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Borea, PA; Dorigo, MT; Dorigo, P; Floreani, M; Froldi, G; Quintieri, L; Varani, K | 1 |
2 other study(ies) available for xamoterol and carteolol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
In vitro evidence that carteolol is a nonconventional partial agonist of guinea pig cardiac beta1-adrenoceptors: a comparison with xamoterol.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Carteolol; Female; Guinea Pigs; Heart; In Vitro Techniques; Molecular Structure; Receptors, Adrenergic, beta-1; Xamoterol | 2005 |